Clinical Trial Update: Study of Duloxetine in Elderly Patients With Major Depressive Disorder [Phase 3]

View source ↗

Summary

Duloxetine was studied in a Phase 3 trial in elderly patients with major depressive disorder. The trial status is completed, with an update on the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Major Depressive Disorder

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Depression, Cognition | Phase 3 | Status: COMPLETED